Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19

Schilling WHK., Jittamala P., Watson JA., Ekkapongpisit M., Siripoon T., Ngamprasertchai T., Luvira V., Pongwilai S., Cruz C., Callery JJ., Boyd S., Kruabkontho V., Ngernseng T., Tubprasert J., Abdad MY., Piaraksa N., Suwannasin K., Hanboonkunupakarn P., Hanboonkunupakarn B., Sookprome S., Poovorawan K., Thaipadungpanit J., Blacksell S., Imwong M., Tarning J., Taylor WRJ., Chotivanich V., Sangketchon C., Ruksakul W., Chotivanich K., Teixeira MM., Pukrittayakamee S., Dondorp AM., Day NPJ., Piyaphanee W., Phumratanaprapin W., White NJ.

DOI

10.1101/2022.07.15.22277570

Type

Publication Date

19/07/2022

Permalink Original publication